MedQuist, Inc
Article Abstract:
A comparative analysis of the company sales and financial details of MedQuist, Inc. from 1992 to 2002 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Clorox Co
Article Abstract:
Clorox Co. which is focusing on cost-cutting, is expected to post record results for 2003 but its issue, which is timely, does not offer significant 3 - 5 year price gains potential. CEO Craig Sullivan is retiring.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Medquist Inc.
Article Abstract:
Medquist Inc.'s CEO, David Cohen, is retiring and although share-net growth was modest in 2002, earnings will advance out to 2006-2008 with shares offering risk-tolerant investors wide appreciation potential.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
User Contributions:
Comment about this article or add new information about this topic: